Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia

NCT00084240 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped See Detailed Description

Conditions

Malaria, Falciparum

Interventions

DRUG: Azithromycin/Chloroquine
DRUG: Sulfadoxine-Pyrimethamine/Chloroquine

Sponsor

Pfizer